MIRVAC GROUP (MGR)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MGR

MGR - MIRVAC GROUP

FNArena Sector : Infra & Property Developers
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 6.56
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Mirvac is an Australian property group with a portfolio that includes commercial offices, retail centres and industrial properties across Australia. It is also active in the build to rent sector. The company was founded in 1972 and publicly listed in 1999.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.91

21 Aug
2026

0.010

OPEN

$1.89

0.53%

HIGH

$1.93

13,922,401

LOW

$1.89

TARGET
$2.048 7.2% upside
OTHER COMPANIES IN THE SAME SECTOR
CMW . CWP . FRI . FWD . GLF . GMG . GOZ . GPT . LIC . LLC . PPC . SFC . SGP . SIO . UOS .
FNARENA'S MARKET CONSENSUS FORECASTS
MGR: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 17.2 13.2 xxx
DPS (cps) xxx 9.5 10.2 xxx
EPS Growth xxx 100.0% - 23.1% xxx
DPS Growth xxx 5.6% 7.4% xxx
PE Ratio xxx N/A 14.4 xxx
Dividend Yield xxx N/A 5.4% xxx
Div Pay Ratio(%) xxx 55.4% 77.3% xxx

Dividend yield today if purchased 3 years ago: 4.06%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

5.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/06 - (franking ex-div 4.80c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx17.2
DPS All xxxxxxxxxxxxxxx9.5
Sales/Revenue xxxxxxxxxxxxxxx2,619.0 M
Book Value Per Share xxxxxxxxxxxxxxx237.1
Net Operating Cash Flow xxxxxxxxxxxxxxx875.0 M
Net Profit Margin xxxxxxxxxxxxxxx25.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx7.35 %
Return on Invested Capital xxxxxxxxxxxxxxx5.26 %
Return on Assets xxxxxxxxxxxxxxx4.48 %
Return on Equity xxxxxxxxxxxxxxx7.35 %
Return on Total Capital xxxxxxxxxxxxxxx3.89 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx509.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx579 M
Long Term Debt xxxxxxxxxxxxxxx3,253 M
Total Debt xxxxxxxxxxxxxxx3,832 M
Goodwill - Gross xxxxxxxxxxxxxxx67 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx238 M
Price To Book Value xxxxxxxxxxxxxxx0.73

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx4.0 M
Capex % of Sales xxxxxxxxxxxxxxx0.15 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,826 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx272 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx8,938 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

20/08/2026

3

Neutral

$1.99

4.19%

On further inspection, UBS lifts the target price to $1.99 from $1.97. Neutral rating retained.

EPS forecasts are tweaked lower by -1.5% for FY27 and -1.4% for FY28.

First Take: UBS notes Mirvac Group's FY26 result was broadly in line, with operating EPS of 12.9c matching expectations, and FY27 guidance for 13.2c–13.4c also as anticipated.

Residential development was a key positive, with FY27 settlement guidance of 2,800–3,100 lots well above the broker's forecast and consensus.

Commentary states it is difficult to reconcile with modest EPS growth and implies weaker expectations elsewhere in development.

A $200m on-market buyback is considered a positive, while 4Q26 residential sales softened –11% q/q and –15% on pcp.

Neutral. Target $1.97.

FORECAST
UBS forecasts a full year FY27 dividend of 10.00 cents and EPS of 13.00 cents.
UBS forecasts a full year FY28 dividend of 11.00 cents and EPS of 14.00 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

24/08/2026

1

Buy

$2.28

19.37%

Jarden maintains its Buy recommendation for Mirvac Group with its target price increased to $2.28 from $2.24 following an FY26 result marked by operating earnings per share of 12.9c matching consensus expectations alongside a $200m buyback announcement.

Management issued FY27 operating earnings per share guidance of 13.2c to 13.4c, representing a step in the right direction with fewer one-offs and a higher level of absolute return despite room for ongoing return on invested capital improvement.

The company demonstrated lower gearing and debt costs tracking relatively close to current market pricing, implying interest headwinds are a smaller issue compared to other real estate investment trusts.

The analyst suggests the stock remains under the radar and offers more cyclical upside potential across both multiple and earnings metrics.

The broker's estimates highlight a supportive FY27 price-to-earnings multiple of 14x and a three-year operating earnings per share compound annual growth rate of 8%.

MGR STOCK CHART